CRL
Charles River Laboratories
277.30$
-2.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.3% | 21.0% | 17.7% | 17.0% | 19.5% | 18.3% | 18.7% | 21.5% | 15.6% | 16.6% | 18.1% | 18.4% | |
| 7.4% | 7.0% | 7.5% | 7.1% | 7.1% | 7.6% | 8.0% | 7.5% | 7.6% | 7.6% | 8.9% | 10.0% | |
| 2.4% | 2.9% | 2.6% | 2.4% | 2.1% | 2.2% | 1.9% | 2.0% | 1.9% | 1.7% | 1.7% | 1.8% | |
| 2.1% | 2.0% | 2.5% | 2.9% | 1.5% | 0.9% | 2.5% | 0.7% | -1.3% | – | – | – | |
| -0.3% | 0.7% | -1.8% | 0.3% | 0.7% | 0.2% | -0.9% | 1.2% | -3.8% | -2.5% | -0.7% | 0.4% | |
| 4.4% | 4.6% | 3.3% | 4.4% | 6.2% | 5.4% | 5.7% | 6.5% | 8.2% | 7.7% | 5.8% | 5.5% | |
| -23.0% | -23.5% | -40.8% | -3.9% | -42.1% | -26.0% | -20.6% | -40.6% | -15.3% | -13.6% | -6.1% | -5.2% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | 1.3% | 1.6% | 1.3% | – | 0.6% | – | – | |
| -9.4% | -8.6% | -0.7% | -5.8% | -0.6% | -0.7% | -0.8% | -1.1% | -1.0% | -0.6% | -2.9% | -9.0% | |
| 8.0% | 5.5% | 23.1% | -7.3% | 23.6% | 8.7% | 1.0% | 18.9% | 0.5% | -1.8% | -10.2% | -3.0% | |
| 4.7% | 0.3% | 23.2% | -11.2% | 24.6% | 8.8% | 1.6% | 19.0% | -1.1% | -2.1% | -13.6% | -13.4% | |
| 0.3% | -3.1% | 0.0% | 2.5% | 1.4% | 1.6% | -0.2% | 0.4% | -0.1% | 1.0% | -1.9% | 0.3% | |
| 15.0% | 16.4% | 14.5% | 12.6% | 13.3% | 13.0% | 13.0% | 15.0% | 7.4% | 8.8% | 12.4% | 12.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.